Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the control of type 2 diabetes. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://orlandohoqw797842.like-blogs.com/38797484/retaglutide-a-promising-glp-1-receptor-agonist